BioAge Labs, Inc.
NASDAQ:BIOABiotechnology
+$0.47 today
- Market cap
- $179.59M
- Beta
- 0.95
- P/E (TTM)
- -9.7
- EPS (TTM)
- -$2.12
Volume 0.64M
Average 0.46M
BIOA Common Stock
The par or stated value of issued common shares, plus paid-in capital where reported together.
BioAge Labs, Inc.NASDAQ: BIOA
Common Stock · Q1 FY2026 · quarter ended Mar 2026
Common stock remains negative
Q1 FY2026 common stock was $0, compared with $0 a year earlier.
Context
- Common stock amounted to 0.0% of total assets at the end of Q1 FY2026, unchanged from a year earlier.
- Common stock increased in 0 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
Sources:Balance SheetText generated from reported figures; not investment advice.
Common Stock history
USD · from the balance sheet
- Latest · FY2025
- 0 USD
- Year-over-year change
- —
| Period | Period end | Common Stock | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 0 | — |
| FY2024 | 2024-12-31 | 0 | — |
| FY2023 | 2023-12-31 | 0 | — |
| FY2022 | 2022-12-31 | 0 | — |
Common Stock vs competitors
How BIOA compares with its peers on the latest reported figures
- Peers report in different currencies, so common stock is compared through growth and share of total assets rather than absolute size.
- Common stock amounts to 0.0% of total assets for BIOA, versus a peer median of 0.0%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | CA$9.23B CAD | +5.0% | +5.2% | 825.4% | |
| Mar 2026 | CA$7.03B CAD | +1.1% | +0.9% | 1165.8% | |
| Mar 2026 | $245K USD | +11.9% | +16.7% | 0.1% | |
| Mar 2026 | $80K USD | -5.9% | -2.0% | 0.0% | |
| Dec 2025 | $37K USD | — | — | 0.0% | |
| Mar 2026 | $23K USD | +43.8% | +26.0% | 0.0% | |
| Mar 2026 | $10K USD | +25.0% | +12.6% | 0.0% | |
| Mar 2026 | $1K USD | +0.0% | — | 0.0% | |
| Mar 2026 | $1K USD | +0.0% | — | 0.0% | |
BIOABioAge Labs, Inc. | Mar 2026 | $0 USD | — | — | 0.0% |
| Peer median (excluding BIOA) | — | +3.0% | +8.9% | 0.0% | |
Competitors are the stored peer set for BIOA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
BioAge Labs, Inc.
NASDAQ:BIOA
Intrinsic Alpha fair value
Locked
Current Price
$4.77
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.